Home / Research library / Hexarelin
Hexarelin: molecular data, studies & sources
Hexarelin is catalogued here as a research compound. This profile brings together the molecular source record, selected indexed publications and available supplier comparisons. Evidence for a named substance does not authenticate a commercial product.
Compiled by PeptideTech Editors · Sources checked · Selected bibliography, not a systematic review
Molecular formula, weight & structure
- Molecular formula (MF)
- C47H58N12O6
- Molecular weight (MW)
- 887.0 g/mol
- PubChem compound ID
- 6918297
- Record title
- Examorelin
Values describe the selected PubChem molecular entity. Counterions, salt forms, hydration and sequence changes can alter the supplied material. Confirm the exact identity against the supplier specification.
Source: PubChem CID 6918297 · retrieved 2026-09-21

Chemical identifiers and source data
- IUPAC name
- (2S)-6-amino-2-[[(2R)-2-[[(2S)-2-[[(2S)-2-[[(2R)-2-[[(2S)-2-amino-3-(1H-imidazol-5-yl)propanoyl]amino]-3-(2-methyl-1H-indol-3-yl)propanoyl]amino]propanoyl]amino]-3-(1H-indol-3-yl)propanoyl]amino]-3-phenylpropanoyl]amino]hexanamide
- InChIKey
- RVWNMGKSNGWLOL-GIIHNPQRSA-N
- SMILES
- CC1=C(C2=CC=CC=C2N1)C[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CC3=CNC4=CC=CC=C43)C(=O)N[C@H](CC5=CC=CC=C5)C(=O)N[C@@H](CCCCN)C(=O)N)NC(=O)[C@H](CC6=CN=CN6)N
Human and clinical studies
Selected human-study records are shown with their indexed or reviewed study type. Check the original article for the intervention, formulation and controls; the molecule can also be a comparator or measured variable.
- Human study · PubMed trial index
Growth hormone response to hexarelin, growth hormone-releasing hormone plus pyridostigmine and arginine plus estrogen in prepubertal and early pubertal short children.
Guzzaloni G, Grugni G, Morabito F et al. · Minerva endocrinologica · 1998
PMID 10361807
- Human study · PubMed trial index
Impact of two or three daily subcutaneous injections of hexarelin, a synthetic growth hormone (GH) secretagogue, on 24-h GH, prolactin, adrenocorticotropin and cortisol secretion in humans.
Maccario M, Veldhuis JD, Broglio F et al. · European journal of endocrinology · 2002
PMID 11888836 · DOI: 10.1530/eje.0.1460310
- Human study · PubMed trial index
Does desensitization to hexarelin occur?
Rahim A, Shalet SM · Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society · 1998
PMID 10990150 · DOI: 10.1016/s1096-6374(98)80039-7
- Human study · PubMed trial index
Effects of cortistatin-14 and somatostatin-14 on the endocrine response to hexarelin in humans.
Benso A, Gottero C, Prodam F et al. · Journal of endocrinological investigation · 2003
PMID 14594107 · DOI: 10.1007/BF03347014
- Human study · PubMed trial index
The effect of an opiate antagonist on the hormonal changes induced by hexarelin.
Korbonits M, Trainer PJ, Besser GM et al. · Clinical endocrinology · 1995
PMID 7586608 · DOI: 10.1111/j.1365-2265.1995.tb02045.x
Preclinical research, reviews & other publications
Animal studies, laboratory experiments, reviews and other indexed papers answer different questions. A review is secondary evidence; a case report does not estimate how often an outcome occurs.
- Review · secondary evidence
The cardiovascular action of hexarelin.
Mao Y, Tokudome T, Kishimoto I et al. · Journal of geriatric cardiology : JGC · 2014
PMID 25278975 · DOI: 10.11909/j.issn.1671-5411.2014.03.007
Hexarelin supplier sources
Scientific sources describe molecules and experiments. The commercial links below identify recorded supplier packages. A publication or chemical database entry does not verify the seller, purity, sterility or contents of a lot. Some links are affiliate links; see our disclosure.
Compare all Hexarelin sizes, forms and supplier prices →
| Supplier | Recorded packages | Example source listing |
|---|---|---|
| Amino USAUSD | 5mg Vial1 recorded offers | 5mg Vial · $40.50Checked Sep 16, 2026Supplier listing |
| Cenexa LabsUSD | 2mg Vial · 5mg Vial2 recorded offers | 2mg Vial · $29.99Checked Sep 16, 2026Supplier listing |
| Direct PeptidesUSD | 10mg Vial1 recorded offers | 10mg Vial · $89.00Checked Sep 16, 2026Supplier listing |
| Particle PeptidesEUR | 5mg Vial1 recorded offers | 5mg Vial · €32.99Checked Sep 16, 2026Supplier listing |
| Blank PeptidesUSD | 10mg Vial1 recorded offers | 10mg Vial · $65.00Checked Sep 21, 2026Supplier listing |
Reference sources & further reading
- PubChem compound record 6918297 — chemical identity and structure.
- Wikipedia: Examorelin — Background encyclopedia; not a primary clinical source.
The citations above link directly to publication records. Encyclopedia links are background reading and are not used to establish clinical effectiveness.
Search for additional research
These links run searches; their results have not been individually reviewed and can include unrelated compounds.
Research information is not a dosing guide or a recommendation for personal use. Study findings are specific to the formulation, population and methods tested. Read our source and correction policy.
Related research profiles
CJC-1295 (DAC)
C165H269N47O46
3647.2 g/mol · PubChem CID 91971820
2 selected publications · 2 human study records
CJC-1295 (No DAC)
Molecular identity needs further verification
Source verification pending
0 selected publications · 0 human study records
GHRP-2
C45H55N9O6
818.0 g/mol · PubChem CID 6918245
0 selected publications · 0 human study records
GHRP-6
C46H56N12O6
873.0 g/mol · PubChem CID 4345065
2 selected publications · 1 human study records
IGF-1 DES
Molecular identity needs further verification
5 selected publications · 0 human study records
IGF-1 LR3
Molecular identity needs further verification
2 selected publications · 0 human study records